Knockdown of FOXO6 Inhibits Glycolysis and Reduces Cell Resistance to Paclitaxel in HCC Cells via PI3K/Akt Signaling Pathway

PURPOSE: Previous studies have reported that FOXO6 is highly expressed in hepatocellular carcinoma (HCC) tissues and is associated with the prognosis of HCC patients. However, little research has been carried out to explore the role of FOXO6 in glycolysis of HCC cells and paclitaxel resistance. Toda...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xixiang, Gao, Xixi, Mao, Xiaoping, Shi, Zhenjing, Zhu, Bangxuan, Xie, Linqin, Di, Shaodan, Jin, Limin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037170/
https://www.ncbi.nlm.nih.gov/pubmed/32110051
http://dx.doi.org/10.2147/OTT.S233031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037170/
https://www.ncbi.nlm.nih.gov/pubmed/32110051
http://dx.doi.org/10.2147/OTT.S233031

Ejemplares similares